FDBusiness.com

GlaxoSmithKline to Sell Lucozade and Ribena Brands

 Breaking News
  • Heineken Delivers Strong Top-line Growth in 2019 Global brewer Heineken achieved 5.6% organic growth in net revenue (beia) to €23.894 billion for 2019 and operating profit grew 3.9% organically to €4.020 billion. However, the operating profit margin...
  • Molson Coors Partners With e.fundamentals to Help Drive UK Online Sales Molson Coors, one of the world’s largest brewers, has partnered with ecommerce analytics provider e.fundamentals to help drive sales of its beers through retailers’ websites in the UK. E.fundamentals’ service...
  • Manor Farm Wins IFSA Best Sustainable Food Product Award 2020 Irish chicken producer Manor Farm has won the IFSA (Irish Foodservice Suppliers Alliance) Best Sustainable Food Product Award 2020. Manor Farm, received the award for the company’s ‘Farmers to Market’...
  • Heineken Announces CEO Succession Jean-François van Boxmeer (pictured left), Chairman and CEO of Heineken, is to step down following his successful 15 year leadership of the company. He will be succeeded by Dolf van...
  • DMK Group Aims to Optimise Ice Cream Production DMK Group, Germany’s largest dairy co-operative, intends to streamline the production network in its ice cream business unit. This involves selling its Waldfeucht-Haaren production site in North Rhine-Westphalia. Schwarz Produktion,...

GlaxoSmithKline to Sell Lucozade and Ribena Brands

GlaxoSmithKline to Sell Lucozade and Ribena Brands
April 26
15:44 2013

UK-based global pharmaceutical and healthcare group GlaxoSmithKline has decided to dispose of its Lucozade glucose energy and sports drinks, and Ribena fruit juice-based drinks brands. The two brands are part of GSK’s Nutrition business which is incorporated within the group’s Consumer Healthcare division. The disposal is part of GSK’s efforts to reshape its business, improve strategic focus and enhance its growth profile.

“In April 2013, we completed the strategic review of our nutritional drinks brands Lucozade and Ribena and concluded that the tremendous growth potential of these iconic brands, particularly outside the ‘core’ Western markets, could be better leveraged by companies with existing category presence and infrastructure in these regions,” explains Sir Andrew Witty, chief executive of GlaxoSmithKline. “As a result, we have decided to pursue the divestment of these brands, subject to the realisation of appropriate value for GSK shareholders.”

GSK’s Nutrition sales grew 6% to £280 million in the first quarter. The category performance was driven by strong growth of the Horlicks brand inIndia(up 16%) and the Boost energy drink (up 23%). Ribena sales grew 2% but Lucozade was down 2%.


Warning: count(): Parameter must be an array or an object that implements Countable in /home/fdbusiness/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share

About Author

mike

mike

Related Articles

Food & Drink Business Conference & Exhibition 2016

Upcoming Events

[eventlist]

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber

Subscribe Here



Advertisements